Elshaer, Sally L.
Alwhaibi, Abdulrahman
Mohamed, Riyaz
Lemtalsi, Tahira
Coucha, Maha
Longo, Frank M.
El-Remessy, Azza B. http://orcid.org/0000-0003-4386-1989
Funding for this research was provided by:
National Eye Institute (R0-1-EY-022408)
Jean Perkins Foundation
American Heart Association (15PRE22830019)
Article History
Received: 5 December 2018
Accepted: 28 March 2019
First Online: 9 May 2019
Duality of interest
: FML is listed as an inventor on patents relating to LM11A-31, which are assigned to UNC and UCSF, and is eligible for royalties distributed by the assigned universities. FML has a financial interest in PharmatrophiX, a company focused on the development of small-molecule ligands for neurotrophin receptors, which has licensed several of these patents. All other authors declare that there is no duality of interest associated with their contribution to this manuscript.
Free to read: This content has been made available to all.